SIKO v. ASTRAZENECA PHARMACEUTICALS LP

CourtDistrict Court, W.D. Pennsylvania
DecidedSeptember 9, 2024
Docket2:23-cv-01184
StatusUnknown

This text of SIKO v. ASTRAZENECA PHARMACEUTICALS LP (SIKO v. ASTRAZENECA PHARMACEUTICALS LP) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SIKO v. ASTRAZENECA PHARMACEUTICALS LP, (W.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA

TAMMY SIKO, ) ) Plaintiff, ) Civil Action No. 23-1184 ) v. ) District Judge W. Scott Hardy ) Magistrate Judge Maureen P. Kelly ASTRAZENECA PHARMACEUTICALS ) LP, ) ) Defendant. )

MEMORANDUM AND ORDER OF COURT This employment discrimination action comes before the Court on Plaintiff Tammy Siko’s objections (Docket No. 35) to the Report and Recommendation (Docket No. 33) (“R&R”) entered by Magistrate Judge Maureen P. Kelly on April 2, 2024. The R&R recommends that the Partial Motion to Dismiss the Amended Complaint (Docket No. 20), filed by Defendant AstraZeneca Pharmaceuticals LP, be granted, that Counts II and III be dismissed pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim upon which relief can be granted, and that Plaintiff be given leave to file a second amended complaint to correct the identified pleading deficiencies as to the two claims addressed therein. (Docket No. 33 at 1, 12). Service of the R&R was made on the parties through the Court’s CM/ECF system, and the parties were advised that any objections to same were due by April 16, 2024. (Docket No. 33 at 12 and docket text entry). On April 16, 2024, Plaintiff filed her objections to the R&R. (Docket No. 34, re-docketed at Docket No. 35). On April 30, 2024, Defendant filed its response in opposition to Plaintiff’s objections. (Docket No. 36). On July 10, 2024, Defendant filed a Notice of Supplemental Authority in support of its motion. (Docket No. 37). I. Background In the Amended Complaint, Plaintiff alleges that she is a Christian over the age of 40 who worked for Defendant as a field-based sales specialist. (Docket Nos. 19, ¶¶ 7, 18; 35 at 1). According to the Amended Complaint, Defendant subjected Plaintiff to discriminatory treatment at work and terminated her employment because she did not comply with Defendant’s policy

requiring its employees to be vaccinated against COVID-19, a requirement for which she was denied a religious exemption. (Docket No. 35 at 2-3). Plaintiff alleges three claims against Defendant: Count I, religious discrimination under Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq. (“Title VII”); Count II, disability discrimination under the Americans with Disabilities Act of 1990, 42 U.S.C. § 12101 et seq. (the “ADA”); and Count III, age discrimination under the Age Discrimination in Employment Act of 1967, 29 U.S.C. § 621 et seq. (the “ADEA”). (Docket No. 19 at 6-11). Defendant, in its motion to dismiss, seeks dismissal of only Count II – ADA and Count III – ADEA. In her objections to the R&R, Plaintiff opposes Judge Kelly’s recommendation that

Defendant’s Partial Motion to Dismiss the Amended Complaint be granted and that Plaintiff’s claims under both the ADA and the ADEA be dismissed. (Docket No. 35). With regard to her ADA claim, Plaintiff argues that she has averred facts in the Amended Complaint that plausibly give rise to an entitlement to relief for a “regarded as” claim under the ADA, and that Judge Kelly erred in making a recommendation to the contrary. (Id. at 4). In her objections, Plaintiff asserts that she, who was not vaccinated against COVID-19, was physically different from Defendant’s employees who had received the COVID-19 vaccine, and that Defendant, albeit mistakenly, perceived that physical difference as suffering from a “physical impairment” of “being immunocompromised, i.e., either having COVID-19 and/or having substantially greater susceptibility to contracting COVID-19 and passing it on to others.” (Id. at 6). In response to Plaintiff’s objections, Defendant argues that Plaintiff is asserting for the first time in her objections that Defendant perceived her as being immunocompromised, and that there are no plausible factual allegations in the Amended Complaint to support such averment. (Docket No. 36 at 5 n.1). Defendant also asserts that “[p]erceiving an individual as at risk for a future disability does not fall

within the scope of an ADA regarded as claim because the ADA does not prohibit discrimination based on future impairments.” (Id. at 7). Defendant further notes that impairments that are transitory and minor are excluded from the “regarded as” disabled definition, so to the extent Plaintiff alleges that Defendant erroneously regarded her as having contracted COVID-19 after one particular meeting referenced in the Amended Complaint, that claim fails as well. (Id. at 8). As to her ADEA claim, Plaintiff challenges Judge Kelly’s recommendation that Plaintiff has not plausibly alleged an entitlement to relief under that statute. (Docket No. 35 at 8). In support of her ADEA claim, Plaintiff alleges that a high-ranking executive of Defendant made a statement during a presentation to the company’s sales managers that the company should aim to

hire individuals who are close to 29 years of age, and that Defendant’s mandatory vaccine policy was later enacted, in part, to remove employees over the age of 40. (Id.). Plaintiff argues that it can be reasonably inferred that Defendant’s employees would view the executive’s statement – which reflects discriminatory animus and cannot be fairly characterized as a “stray remark” – as a company policy to be followed, and that the two-month period of time between that statement and the enactment of the vaccination policy is sufficiently suggestive of causation here. (Id. at 9-10). In response to Plaintiff’s objections, Defendant argues that Plaintiff has merely pled barebones allegations that were properly rejected in the R&R, as Plaintiff only repeats in her objections the conclusory allegation that a statistically significant portion of unvaccinated employees who were denied religions exemptions to the vaccination policy were field-based sales employees over the age of 40 (like Plaintiff). (Docket No. 36 at 9). Defendant also argues that the executive’s stray remark is, as pled, completely untethered from Defendant’s decision to termination Plaintiff for failure to comply with the company’s vaccine requirement. (Id.). Defendant asserts that Plaintiff’s allegations do not establish that her termination occurred under circumstances creating an

inference that her age was a motivating factor, and that the Court should adopt Judge Kelly’s recommendation that Plaintiff’s ADEA claim be dismissed. (Id. at 10). II. Discussion The Federal Rules of Civil Procedure provide that a party may file specific written objections to the proposed findings and recommendations of a magistrate judge, and a district judge must conduct a de novo review of any part of the R&R that has been properly objected to. See Fed. R. Civ. P. 72(b)(2), (b)(3); 28 U.S.C. § 636(b)(1). The Court may accept, reject, or modify the recommended disposition, as well as receive further evidence or return the matter to the magistrate judge with instructions. See id. Upon careful de novo review of the R&R and the entire

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sutton v. United Air Lines, Inc.
527 U.S. 471 (Supreme Court, 1999)
Bostock v. Clayton County
590 U.S. 644 (Supreme Court, 2020)
Roller v. Riley Riper Hollin & Colagreco
850 F. Supp. 2d 502 (E.D. Pennsylvania, 2012)
Rubano v. Farrell Area School District
991 F. Supp. 2d 678 (W.D. Pennsylvania, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
SIKO v. ASTRAZENECA PHARMACEUTICALS LP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/siko-v-astrazeneca-pharmaceuticals-lp-pawd-2024.